Cutler Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-200
Closed -$57K 2408
2022
Q3
$57K Sell
200
-150
-43% -$42.8K ﹤0.01% 840
2022
Q2
$98K Buy
+350
New +$98K 0.01% 678
2022
Q1
Sell
-2,040
Closed -$447K 2625
2021
Q4
$447K Sell
2,040
-1,610
-44% -$353K 0.02% 432
2021
Q3
$662K Hold
3,650
0.03% 352
2021
Q2
$735K Sell
3,650
-1,250
-26% -$252K 0.03% 350
2021
Q1
$1.05M Buy
+4,900
New +$1.05M 0.05% 251
2020
Q4
Hold
0
2426
2020
Q3
Hold
0
2314
2020
Q2
Sell
-900
Closed -$214K 2162
2020
Q1
$214K Sell
900
-2,120
-70% -$504K 0.01% 405
2019
Q4
$661K Sell
3,020
-900
-23% -$197K 0.04% 259
2019
Q3
$664K Sell
3,920
-400
-9% -$67.8K 0.06% 207
2019
Q2
$792K Buy
4,320
+3,800
+731% +$697K 0.07% 176
2019
Q1
$95K Sell
520
-300
-37% -$54.8K 0.01% 647
2018
Q4
$135K Hold
820
0.01% 517
2018
Q3
$158K Hold
820
0.01% 614
2018
Q2
$139K Buy
820
+720
+720% +$122K 0.01% 593
2018
Q1
$16K Sell
100
-27,397
-100% -$4.38M ﹤0.01% 1270
2017
Q4
$4.12M Sell
27,497
-16,991
-38% -$2.55M 0.17% 58
2017
Q3
$6.76M Buy
44,488
+30,259
+213% +$4.6M 0.25% 41
2017
Q2
$1.83M Buy
14,229
+11,204
+370% +$1.44M 0.07% 180
2017
Q1
$330K Sell
3,025
-17,076
-85% -$1.86M 0.01% 619
2016
Q4
$1.48M Buy
20,101
+5,340
+36% +$393K 0.05% 202
2016
Q3
$1.29M Buy
14,761
+13,261
+884% +$1.16M 0.06% 167
2016
Q2
$129K Sell
1,500
-1,273
-46% -$109K 0.01% 890
2016
Q1
$220K Sell
2,773
-5,931
-68% -$471K 0.01% 570
2015
Q4
$1.1M Buy
+8,704
New +$1.1M 0.06% 204